Related Experiment Videos
[Streptococcal tonsillitis: failure of penicillin therapy]
1Aalborg Sygehus, klinisk mikrobiologisk afdeling.
Ugeskrift for Laeger
|March 28, 1994
Summary
Penicillin V therapy fails to eradicate Group A beta-haemolytic streptococci (GAS) in 5-30% of tonsillitis cases. Factors like poor compliance and bacterial resistance contribute to treatment failure, suggesting revised dosing strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Context:
- Group A beta-haemolytic streptococci (GAS) are a common cause of tonsillitis.
- Penicillin V is the standard treatment, but eradication rates vary significantly (5-30%).
- Treatment failures necessitate understanding contributing factors to optimize therapeutic outcomes.
Purpose:
- To analyze the multifactorial reasons behind penicillin V treatment failures in GAS tonsillitis.
- To evaluate the role of bacterial tolerance, beta-lactamase activity, and oral flora in treatment outcomes.
- To provide evidence-based recommendations for improving GAS tonsillitis management.
Summary:
- GAS remains sensitive to penicillin, yet penicillin V fails to eradicate the bacteria in 5-30% of tonsillitis cases.
- Key factors contributing to treatment failure include poor patient compliance, GAS tolerance to penicillin, bacterial inactivation of penicillin by beta-lactamases, and absence of beneficial bacteriocin-producing streptococci.
- Environmental sources are unlikely contributors, and routine post-treatment throat cultures are not recommended.
Impact:
- Highlights the need for further assessment of local immunity's role in GAS tonsillitis.
- Suggests penicillin V remains the preferred agent even in cases requiring re-treatment.
- Recommends exploring multiple dosing schedules for penicillin V in GAS tonsillitis based on pharmacological insights to improve eradication rates and patient outcomes.